Skip to main content
. 2017 Aug 29;7:9711. doi: 10.1038/s41598-017-09859-x

Figure 1.

Figure 1

Combined in-silico and chromatin immunoprecipitation (ChIP) identifies p53 down-stream DNA-binding sites (p53BS) in the DPYD gene. (A) Schematic representation of the approach for in silico screening for putative p53BS within the DPYD gene and 20 kb upstream and downstream of the gene. (B) Fold-enrichment over untreated control of the p53BS (R-0.84) and other binding sites predicted by the in-silico analysis in mouse liver DNA as detected by ChIP analysis following IV 5-FU (150 mg/kg) administration for 6 hr (N = 3). (NS = Not significant) (C) Validation of p53DBS enrichment when treated as in (B), binding to p21 promoter is used as positive control. (N = 3) P-values were determined by multiple t-test.